Your session is about to expire
← Back to Search
Probiotics for Post-Surgery Newborns with Gastrointestinal Disorders (ProPS Trial)
ProPS Trial Summary
This trial will test whether giving neonates probiotics following intestinal surgery will reduce the number of infections they experience.
ProPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowProPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ProPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My infant has a major birth defect, but it's not in the gastrointestinal tract.My baby has an infection confirmed by a positive culture test.Patients who are receiving end-of-life care.I have had surgery on my digestive system.My baby was born between 23 and 41 weeks of pregnancy.I am prepared to begin tube feeding.
- Group 1: Probiotics
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are enrollment opportunities still available for this clinical investigation?
"Affirmative, the clinicaltrials.gov registry displays that this research endeavour is actively seeking participants. It was first publicized on December 3rd 2022 and underwent its most recent edit on November 4th of that same year. At present, 20 people are needed to be enrolled at one medical site."
How many test subjects are actively engaged in this investigation?
"That is correct. According to the information posted on clinicaltrials.gov, this medical trial has opened its recruitment window and is currently seeking 20 patients from a single site. The initial posting of the study was made on December 3rd 2022, with an update being applied as recently as November 4th 2022."
Share this study with friends
Copy Link
Messenger